- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.08. | Kye Pharmaceuticals gains Health Canada approval for Dyanavel XR to treat ADHD | ||
| 05.08. | Minaris Advanced Therapies opens new manufacturing facility in Germany | ||
| 04.08. | Turbine and MSD aim to advance cancer treatment through AI simulations | ||
| 31.07. | Vivace Therapeutics' VT3989 for mesothelioma gains FDA Orphan Drug Designation | ||
| 30.07. | Diorasis, Northway Biotech team up on glaucoma gene therapy development | ||
| 29.07. | AstraZeneca's Imfinzi gains FDA priority review | ||
| 28.07. | CHMP endorses Pfizer-BioNTech's updated Covid-19 vaccine | ||
| 25.07. | Candel Therapeutics' CAN-2409 gains EMA orphan designation | ||
| 24.07. | LEO Pharma's Anzupgo cream receives FDA approval for chronic hand eczema | ||
| 23.07. | Johnson & Johnson, Pacira partner to expand osteoarthritis treatment options | ||
| 22.07. | FDA to review Bristol Myers Squibb's Sotyktu for psoriatic arthritis | ||
| 21.07. | EU approves SpringWorks' Ezmekly for neurofibromatosis type 1 treatment | ||
| 18.07. | Daiichi Sankyo and AstraZeneca's Enhertu gains breakthrough therapy status | ||
| 17.07. | FDA grants fast track designation to Sanofi's SAR446597 | ||
| 16.07. | FDA grants orphan status for AlzeCure's pain drug candidate | ||
| 15.07. | Sun Pharmaceutical launches Leqselvi in US for severe alopecia areata | ||
| 14.07. | Golden Age Health secures rights to promote LX-101 gene therapy in China | ||
| 11.07. | Secarna, Vect-Horus partner to develop RNA-targeted therapeutics | ||
| 10.07. | Simcere Pharmaceutical seeks China approval for atopic dermatitis treatment | ||
| 09.07. | Rallybio sells REV102 programme to Recursion for up to $25m | ||
| 08.07. | Sagent, Qilu partner to commercialise complex injectable products in US | ||
| 07.07. | Biosynth opens expanded GMP bioconjugation facility in Germany | ||
| 04.07. | FDA approves Hikma's Tyzavan for multiple infections | ||
| 03.07. | FDA grants priority review for MSD's Winrevair | ||
| 02.07. | Formycon, Bio Usawa to introduce ophthalmic medicine in Sub-Saharan Africa |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .